Appointments Jobs About Search Education & Research Clinical Trials Health Information Medical Services

Publications - Susan L . Slager, Ph.D.

Back to Research Profile

  1. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol 2009 Nov 06. [Epub ahead of print]
    View PubMed
  2. Cicek MS, Slager SL, Achenbach SJ, French AJ, Blair HE, Fink SR, Foster NR, Kabat BF, Halling KC, Cunningham JM, Cerhan JR, Jenkins RB, Boardman LA, Petersen GM, Sargent DJ, Alberts SR, Limburg PJ, Thibodeau SN. Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev 2009 Sep; 18(9):2492-500.
    View PubMed
  3. Cicek MS, Slager SL, Achenbach SJ, French AJ, Blair HE, Fink SR, Foster NR, Kabat BF, Halling KC, Cunningham JM, Cerhan JR, Jenkins RB, Boardman LA, Petersen GM, Sargent DJ, Alberts SR, Limburg PJ, Thibodeau SN. Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev 2009 Sep; 18(9):2492-500. Epub 2009 Aug 18.
    View PubMed
  4. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009 Aug 20; 27(24):3959-63. Epub 2009 Jul 20.
    View PubMed
  5. Cerhan JR, Novak AJ, Fredericksen ZS, Wang AH, Liebow M, Call TG, Dogan A, Witzig TE, Ansell SM, Habermann TM, Kay NE, Slager SL. Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. Br J Haematol 2009 Jun; 145(5):614-23. Epub 2009 Mar 30.
    View PubMed
  6. Novak AJ, Slager SL, Fredericksen ZS, Wang AH, Manske MM, Ziesmer S, Liebow M, Macon WR, Dillon SR, Witzig TE, Cerhan JR, Ansell SM. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res 2009 May 15; 69(10):4217-24. Epub 2009 Apr 21.
    View PubMed
  7. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009 Apr 30; 113(18):4188-96. Epub 2008 Nov 17.
    View PubMed
  8. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood Blood 2009 Apr 30; 113(18):4188-96 Epub 2008 Nov 17.
    View PubMed
  9. Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res 2009 Feb; 33(2):263-70. Epub 2008 Jul 25.
    View PubMed
  10. Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res 2009 Feb; 33(2):263-70. Epub 2008 Jul 25.
    View PubMed
  11. Shanafelt TD, Jenkins G, Call TG, Zent CS, Slager S, Bowen DA, Schwager S, Hanson CA, Jelinek DF, Kay NE. Validation of a new prognostic index for patients with chronic lymphocytic leukemia. Cancer 2009 Jan 15; 115(2):363-72.
    View PubMed
  12. Peters EJ, Slager SL, Jenkins GD, Reinalda MS, Garriock HA, Shyn SI, Kraft JB, McGrath PJ, Hamilton SP. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics 2009 Jan; 19(1):1-10.
    View PubMed
  13. Zent CS, Ding W, Reinalda MS, Schwager SM, Hoyer JD, Bowen DA, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Kay NE, Slager SL. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leuk Lymphoma 2009; 50(8):1261-8.
    View PubMed
  14. Slager SL, Kay NE. Familial chronic lymphocytic leukemia: what does it mean to me? Clin Lymphoma Myeloma 2009; 9 Suppl 3:S194-7.
    View PubMed
  15. Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2008 Nov; 17(11):3161-9.
    View PubMed
  16. Willett EV, Morton LM, Hartge P, Becker N, Bernstein L, Boffetta P, Bracci P, Cerhan J, Chiu BC, Cocco P, Dal Maso L, Davis S, De Sanjose S, Smedby KE, Ennas MG, Foretova L, Holly EA, La Vecchia C, Matsuo K, Maynadie M, Melbye M, Negri E, Nieters A, Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer 2008 May 1; 122(9):2062-70.
    View PubMed
  17. Zent CS, Ding W, Schwager SM, Reinalda MS, Hoyer JD, Jelinek DF, Tschumper RC, Bowen DA, Call TG, Shanafelt TD, Kay NE, Slager SL. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. Br J Haematol 2008 May; 141(5):615-21. Epub 2008 Mar 27.
    View PubMed
  18. Thurmes P, Call T, Slager S, Zent C, Jenkins G, Schwager S, Bowen D, Kay N, Shanafelt T. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma 2008 Jan; 49(1):49-56.
    View PubMed
  19. Peters EJ, Slager SL, Kraft JB, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP. Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample. PLoS One 2008; 3(4):e1872. Epub 2008 Apr 02.
    View PubMed
  20. Cerhan JR, Liu-Mares W, Fredericksen ZS, Novak AJ, Cunningham JM, Kay NE, Dogan A, Liebow M, Wang AH, Call TG, Habermann TM, Ansell SM, Slager SL. Genetic Variation in Tumor Necrosis Factor and the Nuclear Factor-{kappa}B Canonical Pathway and Risk of Non-Hodgkin's Lymphoma. Cancer Epidemiology Biomarkers & Prevention 2008; 17:3161-9.
    View PubMed
  21. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, Call TG, Dogan A, Cunningham JM, Wang AH, Liu-Mares W, Macon WR, Jelinek D, Witzig TE, Habermann TM, Slager SL. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007 Dec 15; 110(13):4455-63. Epub 2007 Sep 07.
    View PubMed
  22. Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR. Susceptibility genes and B-chronic lymphocytic leukaemia. Br J Haematol 2007 Dec; 139(5):762-71.
    View PubMed
  23. Caporaso N, Goldin L, Plass C, Calin G, Marti G, Bauer S, Raveche E, McMaster ML, Ng D, Landgren O, Slager S. Chronic lymphocytic leukaemia genetics overview. Br J Haematol 2007 Dec; 139(5):630-4.
    View PubMed
  24. Sellick GS, Goldin LR, Wild RW, Slager SL, Ressenti L, Strom SS, Dyer MJ, Mauro FR, Marti GE, Fuller S, Lyttelton M, Kipps TJ, Keating MJ, Call TG, Catovsky D, Caporaso N, Houlston RS. A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia. Blood 2007 Nov 1; 110(9):3326-33. Epub 2007 Aug 08.
    View PubMed
  25. Maddocks-Christianson K, Slager SL, Zent CS, Reinalda M, Call TG, Habermann TM, Bowen DA, Hoyer JD, Schwager S, Jelinek DF, Kay NE, Shanafelt TD. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. Br J Haematol 2007 Nov; 139(3):398-404.
    View PubMed
  26. Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Sloan JA, Call TG. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol 2007 Oct; 139(2):255-64.
    View PubMed
  27. Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, Mensah F, Zhang Y, Nieters A, Dal Maso L, Bracci PM, Costantini AS, Vineis P, Severson RK, Roman E, Cozen W, Weisenburge Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007 Apr 15; 109(8):3479-88.
    View PubMed
  28. Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP. Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 2007 Mar 15; 61(6):734-42.
    View PubMed
  29. de Andrade M, Atkinson EJ, Fridley BL, Goode EL, McDonnell S, Liu-Mares W, Rabe KG, Sun Z, Slager SL. The genetics of gene expression: comparison of linkage scans using two phenotype normalization methods. BMC Proc 2007; 1 Suppl 1:S151. Epub 2007 Dec 18.
    View PubMed
  30. Atkinson EJ, Fridley BL, Goode EL, McDonnell SK, Liu-Mares W, Rabe KG, Sun Z, Slager SL, de Andrade M. Linkage analysis using principal components of gene expression data. BMC Proc 2007; 1(Suppl 1):S79 Epub 2007 Dec 18.
    View PubMed
  31. Goode EL, Fridley BL, Sun Z, Atkinson EJ, Nord AS, McDonnell SK, Jarvik GP, de Andrade M, Slager SL. Comparison of tagging single-nucleotide polymorphism methods in association analyses. BMC Proc 2007; 1 Suppl 1:S6 Epub 2007 Dec 18.
    View PubMed
  32. Teranishi KS, Slager SL, Garriock H, Kraft JB, Peters EJ, Reinalda MS, Jenkins GD, McGrath PJ, Hamilton SP. Variants in PDE11A and PDE1A are not associated with citalopram response. Molecular Psychiatry 2007; 12:1061-63.
    View PubMed
  33. Liu-Mares W, Sun Z, Bamlet WR, Atkinson EJ, Fridley BL, Slager SL, de Andrade M, Goode EL. Analysis of genes and expression levels of downstream targets. BMC Proceedings 2007; 18:S126.
    View PubMed
  34. Goldin LR, Slager SL. Familial CLL: Genes and Environment. Hematology Am Soc Hematol Educ Program 2007; 2007:339-45.
    View PubMed
  35. Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 2006 Feb 20; 24(6):983-7. Epub 2006 Jan 23.
    View PubMed
  36. Slager SL, Zarfas KE, Brown WM, Lange EM, McDonnell SK, Wojno KJ, Cooney KA. Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project. Prostate 2006 Feb 1; 66(2):173-9.
    View PubMed
  37. de Andrade M, Olswold CL, Slusser JP, Tordsen LA, Atkinson EJ, Rabe KG, Slager SL. Identification of genes involved in alcohol consumption and cigarettes smoking. BMC Genet 2005 Dec 30; 6(Suppl 1):S112.
    View PubMed
  38. Kraft JB, Slager SL, McGrath PJ, Hamilton SP. Sequence analysis of the serotonin transporter and associations with antidepressant response. Biol Psychiatry 2005 Sept 1; 58(5):374-81.
    View PubMed
  39. Schaid DJ, Guenther JC, Christensen GB, Hebbring S, Rosenow C, Hilker CA, McDonnell SK, Cunningham JM, Slager SL, Blute ML, Thibodeau SN. Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci. Am J Hum Genet 2004 Dec; 75(6):948-65. Epub 2004 Oct 08.
    View PubMed
  40. Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP. Investigation of serotonin-related genes in antidepressant response. Mol Psychiatry 2004 Sept; 9(9):879-89.
    View PubMed
  41. Hamilton SP, Slager SL, Mayo D, Heiman GA, Klein DF, Hodge SE, Fyer AJ, Weissman MM, Knowles JA. Investigation of polymorphisms in the CREM gene in panic disorder. Am J Med Genet B Neuropsychiatr Genet 2004 Apr 1; 126B(1):111-5.
  42. Hamilton SP, Slager SL, de Leon AB, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 2004 Mar; 29(3):558-65.
    View PubMed
  43. Edland SD, Slager S, Farrer M. Genetic association studies in Alzheimer's disease research: challenges and opportunities. Stat Med 2004 Jan 30; 23(2):169-78.
    View PubMed
  44. Cunningham JM, McDonnell SK, Marks A, Hebbring S, Anderson SA, Peterson BJ, Slager S, French A, Blute ML, Schaid DJ, Thibodeau SN. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic familial prostate cancer study. Prostate 2003 Dec 1; 57(4):335-46.
    View PubMed
  45. Wang L, McDonnell SK, Cunningham JM, Hebbring S, Jacobsen SJ, Cerhan JR, Slager SL, Blute ML, Schaid DJ, Thibodeau SN. No association of germline alteration of MSR1 with prostate cancer risk. Nat Genet 2003 Oct; 35(2):128-9.
    View PubMed
  46. Elkins DA, Yokomizo A, Thibodeau SN, Schaid DJ, Cunningham JM, Marks A, Christensen E, McDonnell SK, Slager S, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Tindall DJ, Liu WG. Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer. Prostate 2003 Jun 15; 56(1):30-6.
    View PubMed
  47. Slager SL, Schaid DJ, Wang L, Thibodeau SN. Candidate-gene association studies with pedigree data: controlling for environmental covariates. Genet Epidemiol 2003 May; 24(4):273-83.
    View PubMed
  48. Slager SL, Schaid DJ, Cunningham JM, McDonnell SK, Marks AF, Peterson BJ, Hebbring SJ, Anderson S, French AJ, Thibodeau SN. Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet 2003 Mar; 72(3):759-62.
    View PubMed
  49. Dong XY, Wang L, Taniguchi K, Wang XS, Cunningham JM, McDonnell SK, Qian CP, Marks AF, Slager SL, Peterson BJ, Smith BI, Cheville JC, Blute ML, Jacobsen SJ, Schaid DJ, Tindall DJ, Thibodeau SN, Liu WG. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003 Feb; 72(2):270-80.
    View PubMed
  50. Slager SL, Iturria SJ. Genome-wide linkage analysis of systolic blood pressure: a comparison of two approaches to phenotype definition. BMC Genetics 2003; 4 Suppl 1:S13.
    View PubMed
  51. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002 Jul; 71(1):116-23.
    View PubMed
  52. Hamilton SP, Slager SL, Heiman GA, Deng ZM, Haghighi F, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22. Biol Psychiatry 2002 Apr 1; 51(7):591-601.
    View PubMed
  53. Slager SL, Carleu L, Chung WK, Jackson T, Winchester RJ, Hodge SE, Gulko PS. The IDDM13 region containing the insulin-like growth factor binding protein-5 (IGFBP5) gene on chromosome 2q33-q36 and the susceptibility to rheumatoid arthritis. Genes and Immunology 2002; 3:110-3.
  54. Levy SM, Slager SL, Warren JJ, Levy BT, Nowak A. Associations of pacifier use, digit sucking, and child care attendance with cessation of breastfeeding. J Fam Pract 2002; 51:U15-9.
    View PubMed
  55. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res 2001 Sept 1; 61(17):6494-9.
    View PubMed
  56. Slager SL, Schaid DJ. Evaluation of candidate genes in case-control studies: a statistical method to account for related subjects. Am J Hum Genet 2001 Jun; 68(6):1457-62.
    View PubMed
  57. Slager SL, Schaid DJ. Case-control studies of genetic markers: power and sample size approximations for Armitage's test for trend. Hum Hered 2001; 52(3):149-53.
    View PubMed
  58. Slager SL, Juo SH, Durner M, Hodge SE. Markov chain Monte Carlo linkage analysis: effect of bin width on the probability of linkage. Genet Epidemiol 2001; 21(Suppl 1):S700-5.
    View PubMed
  59. Jiang Y, Slager SL, Huang J. Genome scan for linkage to asthma using a linkage disequilibrium-lod score test. Genet Epidemiol 2001; 21(Suppl 1):S303-7.
    View PubMed
  60. Slager SL, Foround T, Haghighi F, Spence MA, Hodge SE. Stoppage: an issue for segregation analysis. Genet Epidemiol 2001; 20:329-39.
  61. Slager SL, Huang J, Vieland VJ. Power comparisons between the TDT and two likelihood-based methods for complex traits. Genet Epidemiol 2001; 20:192-209.
    View PubMed
  62. Hamilton SP, Slager S, Helleby L, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AF, Knowles JA. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol Psychiatry 2001; 6:59-65.
    View PubMed
  63. Hamilton SP, Slager SL, Heiman GA, Haghighi F, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA. No genetic linkage or association between a functional promoter polymorphism in the monamine oxidase-a gene and panic disorder. Mol Psychiatry 2000; 5:465-6.
    View PubMed
  64. Slager SL, Huang J, Vieland VJ. The effect of allelic heterogeneity on the power of the transmission/disequilibrium test. Genet Epidemiol 2000; 18:143-56.
    View PubMed
  65. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA. Familial primary-pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000; 67:737-44.
    View PubMed
  66. Collaborative Linkage Study of Autism: Barrett S, Beck JC, Bernier R, Bisson E, Braun TA, Casavant TL, Childress D, Folstein SE, Garcia M, Bardiner MB, Gilman S, Haines JL, Hopkins K, Landa R, Meyer NH, Mullan JA, Nishimura DY, Palmer P, Piven J, Purdy J, An autosomal genomic screen for autism. Am J Med Genet B Neuropsychiatr Genet 1999; 88:609-15.
  67. Levy SM, Kiritsy MC, Slager SL, Warren JJ. Patterns of dietary fluoride supplement use during infancy. J Public Health Dent 1999; 58(3):228-33.
  68. Johnson GK, Payne JB, Fili JM, Reinhardt RA, Organ CC, Slager SL. Development of smokeless tobacco-induced oral mucosal lesions. J Oral Pathol Med 1998; 27:388-94.
    View PubMed
  69. Levy SM, Kiritsy MC, Slager SL, Warren JJ, Kohout FJ. Patterns of fluoride dentifrice use among infants. Pediatr Dent 1997; 19(1):50-5.
    View PubMed
  70. Slager SL, Vieland VJ. Investigating the numerical effects of ascertainment bias in linkage analysis: development of methods and preliminary results. Genet Epidemiol 1997; 14:1119-24.
    View PubMed
  71. Bergus GR, Levy BT, Levy SM, Slager SL, Kiritsy MC. Antibiotic use during the first 200 days of life. Arch Fam Med 1996; 5:523-6.
    View PubMed
  72. Levy BT, Bergus GR, Levy SM, Slager SL, Kiritsy MC. Longitudinal feeding patterns of Iowa infants. Ambulatory Child Health 1996; 2:25-34.


Appointments Contact Us Make A Gift Search

Legal restrictions and terms of use applicable to this site

Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.